We demonstrate feasibility for this integrated imaging methodology to be used as an adjunct in breast cancer surgery for real-time detection of ErbB2 positive cancer cells in lymph nodes and to rapidly assess tumor margins. This evidence concerns the gene ERBB2 and breast carcinoma.